Results 21 to 30 of about 38,229 (186)

Intralesional Quadrivalent Human Papilloma Virus Vaccine Versus Candida Antigen in the Treatment of Multiple Recalcitrant Non-Genital Warts [PDF]

open access: yesDermatology Practical & Conceptual
Introduction: Warts are the most prevalent clinical manifestation of Human papillomavirus (HPV) infections, which vary in morphological pattern depending on the site of the body affected. Objective: To evaluate the safety and efficacy of intralesional
Ibrahim Fouda   +2 more
doaj   +2 more sources

A Study on the Efficacy of Immunotherapy with Purified Protein Derivative for the Treatment of Recalcitrant Warts [PDF]

open access: yesNepal Journal of Dermatology, Venereology & Leprology, 2017
Introduction: There are many treatment modalities of warts, but most of them are destructive therapies which have propensity to cause scarring. Many antigens especially purified protein derivative (PPD)  of tuberculin bacilli are being used for the ...
Neerja Puri
doaj   +4 more sources

A Double‐Blind Randomized Study of Two Doses of Oral Isotretinoin in the Treatment of Recalcitrant Facial Flat Warts: Impact on Quality of Life, Anxiety, and Depression [PDF]

open access: yesHealth Science Reports
Background and Aims Recalcitrant facial flat warts are caused by human papillomavirus and may persist for years despite treatment. Oral isotretinoin administered at a dose of 0.5 mg/kg/day is effective and safe.
María Guadalupe Olguín‐García   +4 more
doaj   +2 more sources

Candida Antigen Immunotherapy for Treatment of Cutaneous Warts: A one-Year Zagazig University-Dermatology Clinic Experience. [PDF]

open access: yesZagazig University Medical Journal, 2021
Background: Warts are widespread cutaneous and mucosal infections caused by human papilloma virus. Resistance to treatment is the main concern while dealing with cutaneous warts. Previous research has defined an ideal wart therapeutic modality as the one
Amany Nassar   +3 more
doaj   +1 more source

Efficacy of intralesional Candida antigen immunotherapy in treatment of recalcitrant warts. [PDF]

open access: yesZagazig University Medical Journal, 2020
Background Despite existence of different therapeutic modalities, treatment of warts especially recalcitrant one remains a continuing challenge as there is no treatment modality exhibited high efficiency and low recurrence rate.
Ayman Marei   +3 more
doaj   +1 more source

Oral isotretinoin for the treatment of dermatologic conditions other than acne: a case series [PDF]

open access: yesDermatology Reports
Dermatophyte infections, also known as tinea, along with viral warts, are common skin conditions that can be difficult to treat, especially when they recur or resist standard therapies.
Abdulrahman Janahi   +5 more
doaj   +2 more sources

Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases

open access: yesOman Medical Journal, 2022
Warts are common benign skin tumors caused by human papilloma viruses. Recalcitrant facial warts tend to be cosmetically embarrassing to patients and difficult to treat for doctors.
Al Mutasim Al-Qassabi   +1 more
doaj   +1 more source

A prospective comparative study of efficacy of intralesional bleomycin injection with intralesional 5-FU injection in resistant palmo-plantar warts

open access: yesClinical Dermatology Review, 2023
Background: Treating of recalcitrant viral verrucae either individually or in combination is inconvenient and frustrating both for patients and treating physician. There is no treatment, which is 100% effective for warts.
Prasoon Sachan   +4 more
doaj   +1 more source

Nonavalent human papillomavirus vaccination as alternative treatment for genital warts. [PDF]

open access: yes, 2020
Genital warts caused by the human papillomavirus (HPV) are the most common sexually transmitted disease and have a negative impact on quality of life.
Bossart, Simon   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy